As CBD Oil Flirts with the Mainstream, Questions About Its … – WebMD

Jessica Singer, stand-up comedian, Los Angeles.

Angela Bryan, PhD, professor of psychology and neuroscience, University of Colorado Boulder; co-director, CUChange Lab.

Paul Armentano, deputy director, NORML.

Staci Gruber, PhD, director, Marijuana Investigations for Neuroscientific Discovery (MIND), McLean Hospital; associate professor of psychiatry, Harvard Medical School.

News release, FDA, Nov. 1, 2017.

The National Academies of Sciences, Engineering, and Medicine: “The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendation’s for Research.”

Bethany Gomez, director of research, Brightfield Group.

Brightfield Group: “Hemp CBD will be a $1 billion market by 2020.”

Michael San Filippo, spokesman, American Veterinary Medical Association.

Martin Lee, co-founder, Project CBD, San Francisco.

Tim Shu, DVM, founder and CEO, VetCBD, Los Angeles.

FDA Advisory Committee, April 19, 2018.

David Baranowski, PhD, director of research, Delivra Corporation, Charlottetown, Prince Edward Island, Canada.

PLOS One: “A reliable and validated LC-MS/MS method for the simultaneous quantification

... read more at: https://www.webmd.com/pain-management/news/20180605/as-cbd-oil-flirts-with-mainstream-questions-mount

Leave a Reply

Your email address will not be published. Required fields are marked *